{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:41:19Z","timestamp":1792665679807,"version":"4.5.0"},"reference-count":13,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publications.ersnet.org\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2026,7,7]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1183\/13993003.01480-2026","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:15:28Z","timestamp":1792664128000},"page":"2601480","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Are lung function measurements necessary to evaluate efficacy of biologics in asthma?"],"prefix":"10.1183","volume":"68","author":[{"given":"William W.","family":"Busse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102203152053000_68.4.2601480.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2032506"},{"key":"2026102203152053000_68.4.2601480.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02196-2025"},{"key":"2026102203152053000_68.4.2601480.3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.pupt.2008.02.005","article-title":"Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma","volume":"21","author":"Gelb","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"2026102203152053000_68.4.2601480.4","unstructured":"Global Initiative for Asthma . Global Strategy for Asthma Management and Prevention, 2026. www.ginasthma.org"},{"key":"2026102203152053000_68.4.2601480.5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/all.70031","article-title":"Predictors of response to biologics for severe asthma: a systematic review and meta-analysis","volume":"81","author":"Rattu","year":"2026","journal-title":"Allergy"},{"key":"2026102203152053000_68.4.2601480.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-9-201105030-00002"},{"key":"2026102203152053000_68.4.2601480.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808991"},{"key":"2026102203152053000_68.4.2601480.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217325"},{"key":"2026102203152053000_68.4.2601480.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01198-9"},{"key":"2026102203152053000_68.4.2601480.10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2026102203152053000_68.4.2601480.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00512-2024"},{"key":"2026102203152053000_68.4.2601480.12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamapediatrics.2025.2044","article-title":"Inflammatory pathways in residual asthma exacerbations among mepolizumab-treated urban children: a secondary analysis of a randomized clinical trial","volume":"179","author":"Altman","year":"2025","journal-title":"JAMA Pediatr"},{"key":"2026102203152053000_68.4.2601480.13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.2025.11227","article-title":"Discovering residual pathways driving asthma exacerbations in the era of biologic therapy","volume":"334","author":"Powell","year":"2025","journal-title":"JAMA"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01480-2026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:15:29Z","timestamp":1792664129000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01480-2026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,10,22]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1183\/13993003.01480-2026"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01480-2026","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}